X4 Pharmaceuticals Stock Quote XFOR - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.66

Bid

0.66

Ask

0.6658

Volume

521,386

0.6525 Day's Range 0.7289

0.5311 52 Week Range 1.60

Market Cap

111.21M

Previous Close

0.7157

Open

0.7289

Last Trade

100

0.66

Last Trade Time

13:22:19

Financial Volume

$ 355,837

VWAP

0.682483

Average Volume (3m)

1,315,845

Shares Outstanding

168,499,514

Dividend Yield

PE Ratio

-1.10

Earnings Per Share (EPS)

-0.6

Revenue

Net Profit

-101.17M

X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad ra... X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.x4pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

X4 Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker XFOR. The last closing price for X4 Pharmaceuticals was $0.72. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of $ 0.5311 to $ 1.60.

X4 Pharmaceuticals currently has 168,499,514 shares outstanding. The market capitalization of X4 Pharmaceuticals is $120.60 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.10.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.03	-4.34782608696	0.69	0.73	0.6525	877912	0.70753692	CS
4	-0.029	-4.20899854862	0.689	0.7399	0.61	711065	0.68955034	CS
12	0.09	15.7894736842	0.57	0.8986	0.5369	1315845	0.69500625	CS
26	-0.8	-54.7945205479	1.46	1.6	0.5311	2213210	0.9933233	CS
52	-0.39	-37.1428571429	1.05	1.6	0.5311	2136854	0.93755349	CS
156	-4.95	-88.2352941176	5.61	6.18	0.5311	1570438	1.32360167	CS
260	-11.52	-94.5812807882	12.18	15	0.5311	977618	1.61818368	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OCTOEightco Holdings Inc	$ 3.7194 (49.37%)	93.6M
INVZWInnoviz Technologies Ltd	$ 0.18 (45.69%)	11.02k
RZLVRezolve AI Ltd	$ 6.8295 (38.81%)	1.49M
SBCSBC Medical Group Holdings Incorporated	$ 9.10 (37.25%)	1.41M
ATGLAlpha Technology Group Limited	$ 1.9544 (35.47%)	1.49M
VTNRVertex Energy Inc	$ 0.1592 (-55.90%)	35.54M
CMCTCreative Media and Community Trust Corporation	$ 0.7692 (-50.85%)	2.44M
SFIXStitch Fix Inc	$ 2.33 (-37.87%)	13.94M
SHOTWSafety Shot Inc	$ 0.22 (-31.25%)	11.2k
BNZIBanzai International Inc	$ 5.70 (-30.83%)	2.46M
NVDANVIDIA Corporation	$ 122.911 (1.69%)	195.35M
CEROCERo Therapeutics Holdings Inc	$ 0.10155 (8.38%)	112.35M
MLGOMicroAlgo Inc	$ 0.2625 (21.42%)	103.59M
OCTOEightco Holdings Inc	$ 3.7102 (49.00%)	93.6M
SQQQProShares UltraPro Short QQQ	$ 7.5101 (-1.83%)	88.66M